Research Library

Drug companies that bypass distributors and offer generics directly to patients, like the Mark Cuban Cost Plus Drug Company, could disrupt the pharmaceutical supply chain and ultimately save thousands of lives.

As false or inaccurate information about stem cell interventions continues to circulate widely, the authors write that immediate action is needed to improve patient education and safety — and to combat misinformation more broadly.

Senior fellow Neal Lane remembers colleague Robert F. Curl.

An overview of the ABA's Cannabis Law & Policy Committee, which is composed of attorneys across North America who have various mainstream practices and who seek to be stewards of historic changes in the pioneering field of marijuana law.

"This pandemic and looming economic crisis will affect all of us ... The sooner we relearn how to set aside our differences and unite during this difficult moment, the stronger we will emerge from it," writes former Secretary James A. Baker, III.

Coronavirus cases in Texas may grow as the state expands COVID-19 screening and the consequences of delayed decisions to limit public interactions set in. "No one should be surprised lim or panic as the figures roll out," write the authors in the Baker Institute Blog.

In the second of a series of blogs on the coronovirus outbreak, the authors sound a note of cautious optimism: "We hope for a relatively optimistic outlook for the COVID-19 pandemic in the United States, with the quick realization of all modifying interventions: earlier and broader testing, strict preventive hygienic and societal measures, a safe and effective vaccine, and effective therapies to treat the virus."  Read more at the Baker Institute Blog.

The COVID-19 outbreak has now reached pandemic proportions, threatening the health of millions worldwide and adversely affecting the international economy. Understanding the status of COVID-19, its potential impact in the U.S., and the needed preventive measures could save many lives.

Products containing hemp extracts high in CBD are gaining mainstream popularity, acceptance and federal legality. In this article, Lisa Pittman, nonresident fellow in drug policy, focuses on litigation issues particular to hemp.